Published in Lancet on June 20, 1992
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Why heart disease mortality is low in France: the time lag explanation. BMJ (1999) 5.44
Mortality associated with moderate intakes of wine, beer, or spirits. BMJ (1995) 4.46
Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ (1996) 4.21
Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev (2010) 4.02
Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med (2014) 2.88
Are the 1976-1985 birth cohorts heavier drinkers? Age-period-cohort analyses of the National Alcohol Surveys 1979-2010. Addiction (2012) 2.42
Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. BMJ (1994) 2.31
Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov (2012) 2.22
High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08
Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol (2008) 2.04
Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol (2010) 1.78
Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc Drugs Ther (2013) 1.69
Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients (2010) 1.66
Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem (2010) 1.65
Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest (1999) 1.55
How does variability in alcohol consumption over time affect the relationship with mortality and coronary heart disease? Addiction (2010) 1.51
Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol (2008) 1.44
Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr (2011) 1.43
Perceptions, Information Sources, and Behavior Regarding Alcohol and Heart Health. Am J Cardiol (2015) 1.42
Resveratrol: French paradox revisited. Front Pharmacol (2012) 1.40
Anthocyanins in cardiovascular disease. Adv Nutr (2011) 1.39
Retracted Can French paradox hypothesis explain the observed different trends of mortality from ischemic heart disease and stroke in Western europe? Int J Prev Med (2013) 1.38
Effects of antioxidant supplementation on the aging process. Clin Interv Aging (2007) 1.35
Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J Biol Chem (2008) 1.33
Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients (2012) 1.33
French cardiovascular mortality did not increase during 1996 European football championship. BMJ (2001) 1.30
The French paradox: lessons for other countries. Heart (2004) 1.28
Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol (2009) 1.27
An ancient duplication of apple MYB transcription factors is responsible for novel red fruit-flesh phenotypes. Plant Physiol (2012) 1.26
Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer (2014) 1.24
Molecular Mechanisms Behind the Chemopreventive Effects of Anthocyanidins. J Biomed Biotechnol (2004) 1.22
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des (2013) 1.22
Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol (2011) 1.21
Willow leaves' extracts contain anti-tumor agents effective against three cell types. PLoS One (2007) 1.21
High-yield resveratrol production in engineered Escherichia coli. Appl Environ Microbiol (2011) 1.21
Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol (2000) 1.20
Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality. Am J Public Health (1999) 1.19
Food buying habits of people who buy wine or beer: cross sectional study. BMJ (2006) 1.19
Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab (2011) 1.18
Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging (2008) 1.17
Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep (2008) 1.17
Carvacrol, a component of thyme oil, activates PPARalpha and gamma and suppresses COX-2 expression. J Lipid Res (2010) 1.16
Joint effect of cigarette smoking and alcohol consumption on mortality. Prev Med (2007) 1.16
Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients (2013) 1.14
How can research on plants contribute to promoting human health? Plant Cell (2011) 1.12
Functional differentiation of the glycosyltransferases that contribute to the chemical diversity of bioactive flavonol glycosides in grapevines (Vitis vinifera). Plant Cell (2010) 1.12
Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res (2011) 1.12
The phytoalexin resveratrol regulates the initiation of hypersensitive cell death in Vitis cell. PLoS One (2011) 1.12
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat (2010) 1.11
A SQUAMOSA MADS box gene involved in the regulation of anthocyanin accumulation in bilberry fruits. Plant Physiol (2010) 1.11
Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur J Pharmacol (2007) 1.10
Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1. Mol Med (2012) 1.09
Grapes and cardiovascular disease. J Nutr (2009) 1.09
Wine and coronary heart disease. Lancet (1992) 1.08
Child and parent characteristics related to parental feeding practices. A cross-cultural examination in the US and France. Appetite (2008) 1.08
Neuronal and cognitive plasticity: a neurocognitive framework for ameliorating cognitive aging. Front Aging Neurosci (2010) 1.07
Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. Br J Pharmacol (2011) 1.07
Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol (2002) 1.06
Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev (2010) 1.04
Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol (2011) 1.03
Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat (2008) 1.03
Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia (2003) 1.03
Botanical flavonoids on coronary heart disease. Am J Chin Med (2011) 1.02
Resveratrol--pills to replace a healthy diet? Br J Clin Pharmacol (2011) 1.02
Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr (2012) 1.02
Structural, functional, and evolutionary analysis of the unusually large stilbene synthase gene family in grapevine. Plant Physiol (2012) 1.01
Renal protective effects of resveratrol. Oxid Med Cell Longev (2013) 0.99
Resveratrol preserves cerebrovascular density and cognitive function in aging mice. Front Aging Neurosci (2009) 0.98
The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol (2002) 0.98
Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels. PLoS One (2011) 0.98
Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet. Mol Cell Proteomics (2010) 0.98
Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans. Oxid Med Cell Longev (2015) 0.97
Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction. FASEB J (2008) 0.97
Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition. Front Aging Neurosci (2014) 0.96
Flavonoids and age-related disease: risk, benefits and critical windows. Maturitas (2010) 0.96
Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PLoS One (2012) 0.95
Hormetic response of resveratrol against cardioprotection. Exp Clin Cardiol (2010) 0.95
Maternal obesity, inflammation, and developmental programming. Biomed Res Int (2014) 0.94
A healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations. Aging (Albany NY) (2013) 0.93
Managing phenol contents in crop plants by phytochemical farming and breeding-visions and constraints. Int J Mol Sci (2010) 0.93
Alcohol consumption, diet, coronary risk factors, and prevalent coronary heart disease in men and women in the Scottish heart health study. J Epidemiol Community Health (1995) 0.93
Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity. Sci Rep (2012) 0.93
Vodka and wine consumption in a swine model of metabolic syndrome alters insulin signaling pathways in the liver and skeletal muscle. Surgery (2012) 0.92
Flavonoid profiling and transcriptome analysis reveals new gene-metabolite correlations in tubers of Solanum tuberosum L. J Exp Bot (2010) 0.92
Alcohol intake and noncoronary cardiovascular diseases. Ann Epidemiol (2007) 0.92
Wine and coronary heart disease. Lancet (1992) 0.92
Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol (2012) 0.92
Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med (2010) 0.91
Platelets and their chemokines in atherosclerosis-clinical applications. Front Physiol (2014) 0.91
Is alcohol beneficial or harmful for cardioprotection? Genes Nutr (2010) 0.91
Experimental evidence for the cardioprotective effects of red wine. Exp Clin Cardiol (2007) 0.91
Some polyphenols inhibit the formation of pentyl radical and octanoic acid radical in the reaction mixture of linoleic acid hydroperoxide with ferrous ions. Biochem J (2000) 0.90
Chemistry and Biology of Resveratrol-Derived Natural Products. Chem Rev (2015) 0.90
Human longevity and common variations in the LMNA gene: a meta-analysis. Aging Cell (2012) 0.90
Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both? Vasc Health Risk Manag (2006) 0.90
Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech (2011) 0.90
Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol (2006) 0.90
Resveratrol and the eye: activity and molecular mechanisms. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
Lipid-lowering drugs and homocysteine. Lancet (1999) 1.97
The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients. Transplantation (1994) 1.45
Effects of a French Mediterranean diet on heart transplant recipients with hypercholesterolemia. Am J Cardiol (1994) 1.40
Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39
HIV infection and immune system in genesis of coronary lesions. Lancet (1992) 1.38
Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res (1993) 1.28
Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr (1995) 1.26
A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients. Eur J Clin Pharmacol (1997) 1.14
Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation (1987) 1.11
Improved myocardial tolerance to ischaemia in the diabetic rabbit. J Mol Cell Cardiol (1998) 0.94
Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI. Magn Reson Imaging (1993) 0.94
Farmed and wild fish in the prevention of cardiovascular diseases: assessing possible differences in lipid nutritional values. Nutr Metab Cardiovasc Dis (2004) 0.93
Gender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population - the IMMIDIET study. Nutr Metab Cardiovasc Dis (2010) 0.89
The French paradox: dietary factors and cigarette smoking-related health risks. Ann N Y Acad Sci (1993) 0.84
Insulin resistance modifies plasma fatty acid distribution and decreases cardiac tolerance to in vivo ischaemia/reperfusion in rats. Clin Exp Pharmacol Physiol (2003) 0.81
Quantitation of reperfused myocardial infarction by Gd-DOTA-enhanced magnetic resonance imaging. An experimental study. Invest Radiol (1991) 0.81
Dietary habit profile in European communities with different risk of myocardial infarction: the impact of migration as a model of gene-environment interaction. The IMMIDIET Study. Nutr Metab Cardiovasc Dis (2001) 0.81
Wine ethanol, platelets, and Mediterranean diet. Lancet (1999) 0.80
Dietary lipids and their relation to ischaemic heart disease: from epidemiology to prevention. J Intern Med Suppl (1989) 0.79
Effect of colchicine on circulating and myocardial neutrophils and on infarct size in a canine model of ischemia and reperfusion. J Cardiovasc Pharmacol (1996) 0.79
Acute influence of cigarette smoke in platelets, catecholamines and neurophysins in the normal conditions of daily life. Eur Heart J (1985) 0.79
Noninvasive assessment of no-reflow phenomenon in a canine model of reperfused infarction by contrast-enhanced magnetic resonance imaging. Am Heart J (1995) 0.78
Importance of initial coronary artery flow after heart procurement to assess heart viability before transplantation. Circulation (1995) 0.78
Factors affecting left ventricular function after correction of tetralogy of Fallot. Br Heart J (1984) 0.78
Is alcohol anti-inflammatory in the context of coronary heart disease? Heart (2004) 0.77
Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients. J Heart Lung Transplant (1996) 0.77
Dietary arginine and the prevention of cardiovascular diseases. Cardiovasc Res (1998) 0.77
Inhibition of coronary artery thrombosis by SIN-1, a donor of nitric oxide. J Cardiovasc Pharmacol (1990) 0.77
Effects of dietary supplementation with alpha-tocopherol on myocardial infarct size and ventricular arrhythmias in a dog model of ischemia-reperfusion. J Am Coll Cardiol (1994) 0.77
U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion. Am Heart J (1991) 0.77
Mediterranean diet in the prevention of coronary heart disease. Nutrition (1998) 0.76
Lessons from Albania. Lancet (1998) 0.75
GISSI-Prevenzione trial. Lancet (1999) 0.75
Potential use of nuts for the prevention and treatment of coronary heart disease: from natural to functional foods. Nutr Metab Cardiovasc Dis (2001) 0.75
Homocysteine and fibrinolysis in acute occlusive coronary events. Lancet (1999) 0.75
Selenium and chronic heart failure. Circulation (2000) 0.75
Dietary prevention of post-angioplasty restenosis. From illusion and disillusion to pragmatism. Nutr Metab Cardiovasc Dis (2003) 0.75
Nutrition, atherosclerosis and coronary heart disease. Reprod Nutr Dev (1994) 0.75
Leukocytes, thrombosis, and unstable angina. N Engl J Med (1987) 0.75
[Evaluation of non invasive methods for the diagnosis of atherosclerosis of the graft after orthotopic cardiac transplantation]. Arch Mal Coeur Vaiss (1992) 0.75
Platelets and dietary prevention of coronary heart disease (CHD). Acta Cardiol (1993) 0.75
Low-dose aspirin and accelerated coronary disease in heart transplant recipients. J Heart Transplant (1990) 0.75
[Possible role of vasopressin in ischemic accidents related to tobacco consumption]. Arch Mal Coeur Vaiss (1984) 0.75
Effect of chronic oral supplementation with alpha-tocopherol on myocardial stunning in the dog. J Cardiovasc Pharmacol (1997) 0.75
[The natural history of coronary disease. The role of cholesterol]. Ann Cardiol Angeiol (Paris) (1990) 0.75
[Late potentials: non-invasive detection in coronary disease and relation to severe ventricular arrhythmia]. Ann Cardiol Angeiol (Paris) (1985) 0.75
Effect of trimetazidine on postischemic regional myocardial stunning in the halothane-anesthetized dog. J Cardiovasc Pharmacol (1996) 0.75
[Value of coronary angiography in the diagnosis of coronary artery disease of the transplanted heart. Coronary angiography and arteriosclerosis of the graft]. Arch Mal Coeur Vaiss (1995) 0.75
Increased lipid peroxidation in cyclosporin-treated heart transplant recipients. Am J Cardiol (1991) 0.75
[Hyperlipidemias. Concern with the Mediterranean diet]. Presse Med (1999) 0.75
[Isotope angiocardiography: amelioration of the measurement of ejection fraction by a new treatment of the image]. Schweiz Med Wochenschr (1981) 0.75
[Endogenous prostacycline and coronaropathy. Plasma levels of 6-keto-PGF1 alpha]. Arch Mal Coeur Vaiss (1985) 0.75
[Non-invasive detection of late potentials of ventricular activation: identification and significance in coronary disease]. Schweiz Med Wochenschr (1983) 0.75
Clinical epidemiology and experimental biology in cardiology: the two faces of the same coin. Eur Heart J (1994) 0.75
Effect of chronic severe diabetes on myocardial stunning in the dog. J Mol Cell Cardiol (1998) 0.75